UPL Retains FY27 Guidance Targeting 7% to 11% Revenue Growth Post Q2

Market snapshot: UPL Limited has reaffirmed its full-year guidance for FY27, targeting revenue growth between 7% and 11% alongside EBITDA growth of 10% to 14%. Despite global crop protection volume pressures, operational strength in the Advanta seeds business and the Superform specialty chemicals unit expanded Q2 margins by 120 basis points.

Data Snapshot

• UPL Q2FY27 consolidated EBITDA rose 5% YoY to ₹2,312 crore, with EBITDA margin expanding 120 bps to 19.5%.
• UPL Q2FY27 consolidated revenue stood flat YoY at ₹11,860 crore as specialty chem and seed growth offset crop protection declines.
• UPL management retained its full-year FY27 guidance of 7% to 11% revenue growth and 10% to 14% EBITDA growth.
• Superform specialty chemicals platform recorded 50% revenue growth in Q2FY27, while Advanta delivered 18% revenue growth in H1FY27.

What's Changed

• Q2FY27 EBITDA margin expanded 120 bps YoY to 19.5% from 18.3% in Q2FY26.
• H1FY27 Operational PATMI expanded 33% YoY to ₹441 crore compared to ₹331 crore in H1FY26.

Key Takeaways

• Specialty chemicals platform Superform surged 50% in Q2FY27, demonstrating rapid scaling in high-margin contract manufacturing.
• Advanta seeds platform maintained double-digit growth momentum, reinforcing structural portfolio diversification away from basic crop protection.
• Management reaffirmed its target leverage metric of 1.5x Net Debt to EBITDA over the medium term.

SAHI Perspective

UPL's structural pivot toward specialized platforms is yielding margin resilience even in a subdued global crop protection pricing environment. While legacy agrochemical volume recovery remains gradual, high-margin contribution from seeds and specialty chemistry provides earnings stability and cash flow backing for balance sheet deleveraging.

Market Implications

The operational resilience in seeds and specialty chemicals protects earnings quality while the broader agrochemical sector navigates inventory normalization. Continuous margin expansion supports credit profile improvement across key operating subsidiaries.

Trading Signals

Market Bias: Bullish

Supported by Q2FY27 EBITDA margin expansion of 120 bps to 19.5% and reaffirmation of 10% to 14% full-year EBITDA growth guidance.

Overweight: Agrochemicals & Specialty Chemicals, Seeds & Post-Harvest

Underweight: Legacy Crop Protection Formulations

Trigger Factors:

• Sustained volume expansion in Superform and Advanta platforms
• Execution of balance sheet deleveraging toward the 1.5x Net Debt to EBITDA target

Time Horizon: Medium-term (3-12 months)

Industry Context

Global crop protection markets face pricing headwinds from increased generic supply and regional volume corrections. Specialized agricultural inputs, high-performance seeds, and custom synthesis specialty chemicals continue to post superior pricing power and structural volume demand.

Key Risks to Watch

• Persistent weakness or delayed volume recovery in core Latin American and European crop protection markets
• Raw material price volatility affecting short-term contribution margins

Recent Developments

Advanta entered into an agreement to acquire a 99.98% stake in Misr Hytech Seed International for approximately $110 million. Additionally, S&P revised UPL Corp's outlook to Positive from Stable, affirming its BB rating, while CRISIL revised UPL Ltd's outlook to Stable from Negative while reaffirming its AA+ rating.

Closing Insight

UPL's multi-platform model provides operational balance, where specialty chemistry and seed technology buffer cyclical headwinds in generic crop protection.

High Performance Trading with SAHI.